Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 146

1.

Metabonomics in Gastroenterology and Hepatology.

Bjerrum JT, Nielsen OH.

Int J Mol Sci. 2019 Jul 25;20(15). pii: E3638. doi: 10.3390/ijms20153638.

2.

Fluorescence-based tracing of transplanted intestinal epithelial cells using confocal laser endomicroscopy.

Bergenheim F, Seidelin JB, Pedersen MT, Mead BE, Jensen KB, Karp JM, Nielsen OH.

Stem Cell Res Ther. 2019 May 27;10(1):148. doi: 10.1186/s13287-019-1246-5.

3.

Methotrexate for inflammatory bowel disease: time for reconsideration.

Nielsen OH, Ainsworth MA, Steenholdt C.

Expert Rev Gastroenterol Hepatol. 2019 May;13(5):407-409. doi: 10.1080/17474124.2019.1596797. Epub 2019 Mar 21. No abstract available.

PMID:
30895827
4.

Biosimilars for Management of Crohn Disease.

Nielsen OH, Ainsworth MA.

Ann Intern Med. 2019 Jan 15;170(2):129-130. doi: 10.7326/M18-3060. Epub 2018 Dec 11. No abstract available.

PMID:
30535358
5.

COX-2-PGE2 Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis.

Li Y, Soendergaard C, Bergenheim FH, Aronoff DM, Milne G, Riis LB, Seidelin JB, Jensen KB, Nielsen OH.

EBioMedicine. 2018 Oct;36:497-507. doi: 10.1016/j.ebiom.2018.08.040. Epub 2018 Sep 3.

6.

Targeting JAK-STAT signal transduction in IBD.

Soendergaard C, Bergenheim FH, Bjerrum JT, Nielsen OH.

Pharmacol Ther. 2018 Dec;192:100-111. doi: 10.1016/j.pharmthera.2018.07.003. Epub 2018 Jul 23. Review.

PMID:
30048708
7.

Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD.

Soendergaard C, Seidelin JB, Steenholdt C, Nielsen OH.

BMJ Open Gastroenterol. 2018 May 31;5(1):e000208. doi: 10.1136/bmjgast-2018-000208. eCollection 2018.

8.

Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies.

Boyd M, Thodberg M, Vitezic M, Bornholdt J, Vitting-Seerup K, Chen Y, Coskun M, Li Y, Lo BZS, Klausen P, Jan Schweiger P, Pedersen AG, Rapin N, Skovgaard K, Dahlgaard K, Andersson R, Terkelsen TB, Lilje B, Troelsen JT, Petersen AM, Jensen KB, Gögenur I, Thielsen P, Seidelin JB, Nielsen OH, Bjerrum JT, Sandelin A.

Nat Commun. 2018 Apr 25;9(1):1661. doi: 10.1038/s41467-018-03766-z.

9.

Role of Vitamin D in the Natural History of Inflammatory Bowel Disease.

Nielsen OH, Rejnmark L, Moss AC.

J Crohns Colitis. 2018 May 25;12(6):742-752. doi: 10.1093/ecco-jcc/jjy025. Review.

PMID:
29529167
10.

Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine.

Christensen R, Heitmann BL, Andersen KW, Nielsen OH, Sørensen SB, Jawhara M, Bygum A, Hvid L, Grauslund J, Wied J, Glerup H, Fredberg U, Villadsen JA, Kjær SG, Fallingborg J, Moghadd SAGR, Knudsen T, Brodersen J, Frøjk J, Dahlerup JF, Bojesen AB, Sorensen GL, Thiel S, Færgeman NJ, Brandslund I, Bennike TB, Stensballe A, Schmidt EB, Franke A, Ellinghaus D, Rosenstiel P, Raes J, Boye M, Werner L, Nielsen CL, Munk HL, Nexøe AB, Ellingsen T, Holmskov U, Kjeldsen J, Andersen V.

BMJ Open. 2018 Feb 8;8(2):e018166. doi: 10.1136/bmjopen-2017-018166.

11.

Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.

Nielsen OH, Soendergaard C, Vikner ME, Weiss G.

Nutrients. 2018 Jan 13;10(1). pii: E82. doi: 10.3390/nu10010082. Review.

12.

Relation between NOD2 genotype and changes in innate signaling in Crohn's disease on mRNA and miRNA levels.

Chen Y, Salem M, Boyd M, Bornholdt J, Li Y, Coskun M, Seidelin JB, Sandelin A, Nielsen OH.

NPJ Genom Med. 2017 Feb 8;2:3. doi: 10.1038/s41525-016-0001-4. eCollection 2017.

13.

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease.

Bjerrum JT, Steenholdt C, Ainsworth M, Nielsen OH, Reed MA, Atkins K, Günther UL, Hao F, Wang Y.

BMC Med. 2017 Oct 16;15(1):184. doi: 10.1186/s12916-017-0949-7.

14.

Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis.

Soendergaard C, Kvist PH, Thygesen P, Reslow M, Nielsen OH, Kopchick JJ, Holm TL.

Int J Mol Sci. 2017 Sep 23;18(10). pii: E2046. doi: 10.3390/ijms18102046.

15.

Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.

Sørensen JØ, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Bélard E, Jess T.

Liver Int. 2018 Mar;38(3):532-541. doi: 10.1111/liv.13548. Epub 2017 Sep 5.

PMID:
28796371
16.

Impact of feedback and monitoring on colonoscopy withdrawal times and polyp detection rates.

Nielsen AB, Nielsen OH, Hendel J.

BMJ Open Gastroenterol. 2017 Jun 1;4(1):e000142. doi: 10.1136/bmjgast-2017-000142. eCollection 2017.

17.

Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based Study.

Bojesen RD, Riis LB, Høgdall E, Nielsen OH, Jess T.

Clin Gastroenterol Hepatol. 2017 Dec;15(12):1900-1907.e2. doi: 10.1016/j.cgh.2017.06.051. Epub 2017 Jul 8.

PMID:
28694132
18.

A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine.

Andersen V, Holmskov U, Sørensen SB, Jawhara M, Andersen KW, Bygum A, Hvid L, Grauslund J, Wied J, Glerup H, Fredberg U, Villadsen JA, Kjær SG, Fallingborg J, Moghadd SAGR, Knudsen T, Brodersen J, Frøjk J, Dahlerup JF, Nielsen OH, Christensen R, Bojesen AB, Sorensen GL, Thiel S, Færgeman NJ, Brandslund I, Stensballe A, Schmidt EB, Franke A, Ellinghaus D, Rosenstiel P, Raes J, Heitmann B, Boye M, Nielsen CL, Werner L, Kjeldsen J, Ellingsen T.

Nutrients. 2017 May 15;9(5). pii: E499. doi: 10.3390/nu9050499.

19.

Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease.

Nielsen OH, Li Y, Johansson-Lindbom B, Coskun M.

Trends Mol Med. 2017 Apr;23(4):362-374. doi: 10.1016/j.molmed.2017.02.002. Epub 2017 Mar 8. Review.

PMID:
28283249
20.

Novel Targeted Therapies for Inflammatory Bowel Disease.

Coskun M, Vermeire S, Nielsen OH.

Trends Pharmacol Sci. 2017 Feb;38(2):127-142. doi: 10.1016/j.tips.2016.10.014. Epub 2016 Dec 1. Review.

PMID:
27916280

Supplemental Content

Loading ...
Support Center